|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11 Pt 1
|
|
pubmed:dateCreated |
2006-6-2
|
|
pubmed:abstractText |
To evaluate the relative prognostic value for specific markers of osteoblast and osteoclast activity while controlling for previously reported prognostic variables among men with hormone-refractory metastatic prostate cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3361-7
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16740758-Aged,
pubmed-meshheading:16740758-Alkaline Phosphatase,
pubmed-meshheading:16740758-Antineoplastic Agents, Hormonal,
pubmed-meshheading:16740758-Bone Neoplasms,
pubmed-meshheading:16740758-Diphosphonates,
pubmed-meshheading:16740758-Disease Progression,
pubmed-meshheading:16740758-Follow-Up Studies,
pubmed-meshheading:16740758-Humans,
pubmed-meshheading:16740758-Imidazoles,
pubmed-meshheading:16740758-Male,
pubmed-meshheading:16740758-Multicenter Studies as Topic,
pubmed-meshheading:16740758-Multivariate Analysis,
pubmed-meshheading:16740758-Peptides,
pubmed-meshheading:16740758-Prognosis,
pubmed-meshheading:16740758-Proportional Hazards Models,
pubmed-meshheading:16740758-Prostatic Neoplasms,
pubmed-meshheading:16740758-Randomized Controlled Trials as Topic,
pubmed-meshheading:16740758-Survival Rate,
pubmed-meshheading:16740758-Treatment Outcome,
pubmed-meshheading:16740758-Tumor Markers, Biological
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Markers of bone metabolism and survival in men with hormone-refractory metastatic prostate cancer.
|
|
pubmed:affiliation |
Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, Ontario, Canada.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
